Recent evidence shows that UCMSC-Exos alleviate IBDs by delivering miR-129-5p, which targets ACSL4 to inhibit ferroptosis and lipid peroxidation, restoring intestinal antioxidant balance and reducing inflammation [157]
Tirzepatide, the first in this class, improves glycemic control by increasing insulin sensitivity and lipid metabolism as well as by reducing body weight
While they perform distinct biochemical roles, their synergistic action is absolutely vital for converting the food we eat into usable cellular energy
Diabetes 71 , 14101423 (2022)
Kojta I, Chaciska M, Bachnio-Zabielska A
NEJM Jordy AB, Christensen MM, Lau J, et al